Prevention of venous thromboembolism in gynecologic oncology surgery

Emma L. Barber*, Daniel L. Clarke-Pearson

*Corresponding author for this work

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Gynecologic oncology patients are at a high-risk of postoperative venous thromboembolism and these events are a source of major morbidity and mortality. Given the availability of prophylaxis regimens, a structured comprehensive plan for prophylaxis is necessary to care for this population. There are many prophylaxis strategies and pharmacologic agents available to the practicing gynecologic oncologist. Current venous thromboembolism prophylaxis strategies include mechanical prophylaxis, preoperative pharmacologic prophylaxis, postoperative pharmacologic prophylaxis and extended duration pharmacologic prophylaxis that the patient continues at home after hospital discharge. In this review, we will summarize the available pharmacologic prophylaxis agents and discuss currently used prophylaxis strategies. When available, evidence from the gynecologic oncology patient population will be highlighted.

Original languageEnglish (US)
Pages (from-to)420-427
Number of pages8
JournalGynecologic oncology
Volume144
Issue number2
DOIs
StatePublished - Feb 1 2017

Fingerprint

Gynecologic Surgical Procedures
Venous Thromboembolism
Population
Morbidity
Mortality

Keywords

  • Deep vein thrombosis
  • Gynecologic surgery
  • Pharmacologic prophylaxis
  • Pulmonary embolism
  • Venous thromboembolism

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this

Barber, Emma L. ; Clarke-Pearson, Daniel L. / Prevention of venous thromboembolism in gynecologic oncology surgery. In: Gynecologic oncology. 2017 ; Vol. 144, No. 2. pp. 420-427.
@article{64d6b2f888e04c009577a04bda6355a8,
title = "Prevention of venous thromboembolism in gynecologic oncology surgery",
abstract = "Gynecologic oncology patients are at a high-risk of postoperative venous thromboembolism and these events are a source of major morbidity and mortality. Given the availability of prophylaxis regimens, a structured comprehensive plan for prophylaxis is necessary to care for this population. There are many prophylaxis strategies and pharmacologic agents available to the practicing gynecologic oncologist. Current venous thromboembolism prophylaxis strategies include mechanical prophylaxis, preoperative pharmacologic prophylaxis, postoperative pharmacologic prophylaxis and extended duration pharmacologic prophylaxis that the patient continues at home after hospital discharge. In this review, we will summarize the available pharmacologic prophylaxis agents and discuss currently used prophylaxis strategies. When available, evidence from the gynecologic oncology patient population will be highlighted.",
keywords = "Deep vein thrombosis, Gynecologic surgery, Pharmacologic prophylaxis, Pulmonary embolism, Venous thromboembolism",
author = "Barber, {Emma L.} and Clarke-Pearson, {Daniel L.}",
year = "2017",
month = "2",
day = "1",
doi = "10.1016/j.ygyno.2016.11.036",
language = "English (US)",
volume = "144",
pages = "420--427",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "2",

}

Prevention of venous thromboembolism in gynecologic oncology surgery. / Barber, Emma L.; Clarke-Pearson, Daniel L.

In: Gynecologic oncology, Vol. 144, No. 2, 01.02.2017, p. 420-427.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Prevention of venous thromboembolism in gynecologic oncology surgery

AU - Barber, Emma L.

AU - Clarke-Pearson, Daniel L.

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Gynecologic oncology patients are at a high-risk of postoperative venous thromboembolism and these events are a source of major morbidity and mortality. Given the availability of prophylaxis regimens, a structured comprehensive plan for prophylaxis is necessary to care for this population. There are many prophylaxis strategies and pharmacologic agents available to the practicing gynecologic oncologist. Current venous thromboembolism prophylaxis strategies include mechanical prophylaxis, preoperative pharmacologic prophylaxis, postoperative pharmacologic prophylaxis and extended duration pharmacologic prophylaxis that the patient continues at home after hospital discharge. In this review, we will summarize the available pharmacologic prophylaxis agents and discuss currently used prophylaxis strategies. When available, evidence from the gynecologic oncology patient population will be highlighted.

AB - Gynecologic oncology patients are at a high-risk of postoperative venous thromboembolism and these events are a source of major morbidity and mortality. Given the availability of prophylaxis regimens, a structured comprehensive plan for prophylaxis is necessary to care for this population. There are many prophylaxis strategies and pharmacologic agents available to the practicing gynecologic oncologist. Current venous thromboembolism prophylaxis strategies include mechanical prophylaxis, preoperative pharmacologic prophylaxis, postoperative pharmacologic prophylaxis and extended duration pharmacologic prophylaxis that the patient continues at home after hospital discharge. In this review, we will summarize the available pharmacologic prophylaxis agents and discuss currently used prophylaxis strategies. When available, evidence from the gynecologic oncology patient population will be highlighted.

KW - Deep vein thrombosis

KW - Gynecologic surgery

KW - Pharmacologic prophylaxis

KW - Pulmonary embolism

KW - Venous thromboembolism

UR - http://www.scopus.com/inward/record.url?scp=85007128544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007128544&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2016.11.036

DO - 10.1016/j.ygyno.2016.11.036

M3 - Review article

C2 - 27890280

AN - SCOPUS:85007128544

VL - 144

SP - 420

EP - 427

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -